Institutional members access full text with Ovid®

Share this article on:

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Lebbé, Celestea,b,c; How-Kit, Alexandred; Battistella, Maximee,b; Sadoux, Aurelief; Podgorniak, Marie-Pierref; Sidina, Irinaa; Pages, Cécilea; Roux, Jennifera; Porcher, Raphaelg,b; Tost, Jorgh; Mourah, Samiab,g,i

doi: 10.1097/CMR.0000000000000088
Letters to the Editor